women and men> 18 years of age Elective Surgery BMI <30, patients who gave consent to free and informed participation in writing to benefit from tooth extraction
Conditions
Interventions
Trade Name: Bridion
Product Name: Bridion
Product Code: 3400957355456
Pharmaceutical Form:
Pharmaceutical form of the placebo: Solution for injection
Route of administration of the placebo: Intraveno
Sponsors
Erasme Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - minor patients; - patients refusing to sign consent; - patients included in another protocol within 3 months; - pregnant or nursing patients; - patients with a history of allergy to Sugammadex; - patients with known neuromuscular disease - patients with renal or hepatic impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Time of appearance of 4 responses to the TOF;Secondary Objective: * Evaluate the recovery time of the ratio 0.9. * Evaluate the four-to-four ratio <0.7 after total recovery. * Watch time at the recovery room.;Primary end point(s): 40 patients included;Timepoint(s) of evaluation of this end point: When all the patients are included | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): date of 1er Juillet;Timepoint(s) of evaluation of this end point: every week | — |
Countries
Belgium
Contacts
Public ContactHead of anesthetics departement
Erasme Hospital
Outcome results
None listed